Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 296

1.

Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes.

Javaloyes P, Miró Ò, Gil V, Martín-Sánchez FJ, Jacob J, Herrero P, Takagi K, Alquézar-Arbé A, Díez MP, Martín E, Bibiano C, Escoda R, Gil C, Fuentes M, García GL, Pérez JMÁ, Jerez A, Tost J, Llauger L, Romero R, Garrido JM, Rodríguez-Adrada E, Sánchez C, Rossello X, Parissis J, Mebazaa A, Chioncel O, Llorens P; ICA-SEMES Research Group.

Eur J Heart Fail. 2019 May 24. doi: 10.1002/ejhf.1502. [Epub ahead of print]

PMID:
31127677
2.

Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions.

Nikolaou M, Chrysohoou C, Georgilas TA, Giamouzis G, Giannakoulas G, Karavidas A, Papadopoulos C, Patsilinakos S, Tziakas D, Parissis J; Hellenic Iron Consensus Group.

Eur J Intern Med. 2019 May 17. pii: S0953-6205(19)30157-8. doi: 10.1016/j.ejim.2019.05.011. [Epub ahead of print] Review.

PMID:
31109847
3.

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.

Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Javanainen T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, Spinar J, Mebazaa A, Lassus J; CardShock investigators.

PLoS One. 2019 May 16;14(5):e0217006. doi: 10.1371/journal.pone.0217006. eCollection 2019.

4.

Oral anticoagulation in patients with chronic kidney disease: A systematic review and meta-analysis.

Malhotra K, Ishfaq MF, Goyal N, Katsanos AH, Parissis J, Alexandrov AW, Alexandrov AV, Tsivgoulis G.

Neurology. 2019 May 21;92(21):e2421-e2431. doi: 10.1212/WNL.0000000000007534. Epub 2019 May 8.

PMID:
31068485
5.

Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients with Cardiogenic Shock - Results from The Cardshock Study.

Lindholm MG, Hongisto M, Lassus J, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Salvatore D, Sionis A, Mebazaa A, Veli-Pekka H, Kober L.

Shock. 2019 Apr 5. doi: 10.1097/SHK.0000000000001353. [Epub ahead of print]

PMID:
30973460
6.

The continuous heart failure spectrum: moving beyond an ejection fraction classification.

Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW.

Eur Heart J. 2019 Apr 8. pii: ehz158. doi: 10.1093/eurheartj/ehz158. [Epub ahead of print]

PMID:
30957868
7.

Imaging Risk in Multisystem Inflammatory Diseases.

Ikonomidis I, Makavos G, Katsimbri P, Boumpas DT, Parissis J, Iliodromitis E.

JACC Cardiovasc Imaging. 2019 Mar 8. pii: S1936-878X(19)30179-2. doi: 10.1016/j.jcmg.2018.06.033. [Epub ahead of print] Review.

PMID:
30878436
8.

The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.

Ikonomidis I, Aboyans V, Blacher J, Brodmann M, Brutsaert DL, Chirinos JA, De Carlo M, Delgado V, Lancellotti P, Lekakis J, Mohty D, Nihoyannopoulos P, Parissis J, Rizzoni D, Ruschitzka F, Seferovic P, Stabile E, Tousoulis D, Vinereanu D, Vlachopoulos C, Vlastos D, Xaplanteris P, Zimlichman R, Metra M.

Eur J Heart Fail. 2019 Apr;21(4):402-424. doi: 10.1002/ejhf.1436. Epub 2019 Mar 12.

PMID:
30859669
9.

Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.

Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M, Varoudi M, Vlastos D, Makavos G, Kostelli G, Βenas D, Lekakis J, Parissis J, Boumpas D, Alexopoulos D, Iliodromitis E.

Clin Res Cardiol. 2019 Mar 11. doi: 10.1007/s00392-019-01443-9. [Epub ahead of print]

PMID:
30859382
10.

Vaccination in Patients With Heart Disease. How Long Should We Wait? Response.

Kadoglou NPE, Parissis J, Seferovic P, Filippatos G.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):516. doi: 10.1016/j.rec.2019.01.002. Epub 2019 Feb 18. English, Spanish. No abstract available.

PMID:
30792014
11.

Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study.

Sionis A, Rivas-Lasarte M, Mebazaa A, Tarvasmäki T, Sans-Roselló J, Tolppanen H, Varpula M, Jurkko R, Banaszewski M, Silva-Cardoso J, Carubelli V, Lindholm MG, Parissis J, Spinar J, Lassus J, Harjola VP, Masip J.

J Intensive Care Med. 2019 Feb 7:885066619828959. doi: 10.1177/0885066619828959. [Epub ahead of print]

PMID:
30732522
12.

Lung ultrasound for the diagnosis of acute heart failure: time to upgrade current indication?

Bistola V, Polyzogopoulou E, Ikonomidis I, Parissis J.

Eur J Heart Fail. 2019 Jan 28. doi: 10.1002/ejhf.1414. [Epub ahead of print] No abstract available.

PMID:
30690832
13.

Pulse wave analysis using the Mobil-O-Graph, Arteriograph and Complior device: a comparative study.

Benas D, Kornelakis M, Triantafyllidi H, Kostelli G, Pavlidis G, Varoudi M, Vlastos D, Lambadiari V, Parissis J, Ikonomidis I.

Blood Press. 2019 Apr;28(2):107-113. doi: 10.1080/08037051.2018.1564236. Epub 2019 Jan 22.

PMID:
30668163
14.

Use of levosimendan in acute heart failure.

Harjola VP, Giannakoulas G, von Lewinski D, Matskeplishvili S, Mebazaa A, Papp Z, Schwinger RHG, Pollesello P, Parissis JT.

Eur Heart J Suppl. 2018 Dec;20(Suppl I):I2-I10. doi: 10.1093/eurheartj/suy039. Epub 2018 Dec 11.

15.

Beneficial Effects of Vaccination on Cardiovascular Events: Myocardial Infarction, Stroke, Heart Failure.

Fountoulaki K, Tsiodras S, Polyzogopoulou E, Olympios C, Parissis J.

Cardiology. 2018;141(2):98-106. doi: 10.1159/000493572. Epub 2018 Nov 14.

16.

Pulse wave velocity to global longitudinal strain ratio in hypertension.

Ikonomidis I, Katsanos S, Triantafyllidi H, Parissis J, Tzortzis S, Pavlidis G, Trivilou P, Makavos G, Varoudi M, Frogoudaki A, Vrettou AR, Vlastos D, Lekakis J, Iliodromitis E.

Eur J Clin Invest. 2019 Feb;49(2):e13049. doi: 10.1111/eci.13049. Epub 2018 Dec 19.

PMID:
30422317
17.

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.

Cardiovasc Drugs Ther. 2018 Dec;32(6):617-624. doi: 10.1007/s10557-018-6838-2. Review.

18.

Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation.

Miró Ò, Javaloyes P, Gil V, Martín-Sánchez FJ, Jacob J, Herrero P, Marco-Hernández J, Ríos J, Harjola VP, Torres-Gárate R, Alonso MI, Piñera P, Mecina AB, Escoda R, Müller C, Parissis J, Llorens P; ICA-SEMES Research Group researchers.

Am J Cardiol. 2019 Jan 1;123(1):84-92. doi: 10.1016/j.amjcard.2018.09.021. Epub 2018 Sep 26.

PMID:
30360888
19.

Implantable devices to monitor patients with heart failure.

Karamichalakis N, Parissis J, Bakosis G, Bistola V, Ikonomidis I, Sideris A, Filippatos G.

Heart Fail Rev. 2018 Nov;23(6):849-857. doi: 10.1007/s10741-018-9742-8. Review.

PMID:
30284661
20.

Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing.

Farmakis D, Davlouros P, Giamouzis G, Giannakoulas G, Pipilis A, Tsivgoulis G, Parissis J.

Cardiology. 2018;140(2):126-132. doi: 10.1159/000489922. Epub 2018 Jul 5. Review.

Supplemental Content

Loading ...
Support Center